companydata.dkcompanydata.dk

Mundipharma A/S: Financial statements 2024

CVR: 17981994

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Mundipharma A/S (CVR 17981994) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 26,430,000 and a net result of DKK 514,000 compared with DKK 897,000 the year before. That is a decrease of 26.5% compared with the year before. The profit margin was 1.9%. Equity in the 2024 report amounted to DKK 37,493,000. The solvency ratio was 69.5%. The company had 2 employees in the financial year.

Revenue
DKK 26,430,000
Gross Profit
DKK 3,057,000
Profit/Loss
DKK 514,000
Equity
DKK 37,493,000
Total Assets
DKK 53,921,000
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202426.4M3.1M514K37.5M2
202335.9M3.1M897K37M2
202240.1M6.8M709K49.8M4
202148.5M10.5M910K49.1M9
202051.6M30.8M908K48.2M21

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Lisbeth Kattenhøj joins the board of Mundipharma A/SJul 26, 2024

As of July 26, 2024, Lisbeth Kattenhøj has joined the board of directors of Mundipharma A/S.

Hywel Rhys Day leaves the board of Mundipharma A/SJul 26, 2024

As of July 26, 2024, Hywel Rhys Day has left the board of directors of Mundipharma A/S.

Floris Anne Everard Bongenaar leaves the board of Mundipharma A/SJul 26, 2024

As of July 26, 2024, Floris Anne Everard Bongenaar has left the board of directors of Mundipharma A/S.

Lisbeth Kattenhøj joins Mundipharma A/S as directorJul 26, 2024

As of July 26, 2024, Lisbeth Kattenhøj is registered as director of Mundipharma A/S.

Hywel Rhys Day steps down as adm. dir. of Mundipharma A/SJul 26, 2024

As of July 26, 2024, Hywel Rhys Day has stepped down as adm. dir. of Mundipharma A/S.

Mundipharma A/S: The 2023 annual report is outJun 3, 2024

Mundipharma A/S has published its annual report for 2023. Revenue came to DKK 35,938,000, and the net result was DKK 897,000.

About Mundipharma A/S

Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.

Source: annual report 2025, Danish Business Authority